NEW YORK, May 10, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Fetal Monitoring, Diagnostics and Predictive Tests
http://www.reportlinker.com/p0490902/Fetal-Monitoring-Diagnostics-and-Predictive-Tests.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics
An overview of the market for fetal monitoring, diagnostics, and predictive tests. Analysis of market trends, with data from 2009, estimates for 2010, and projections of compound annual growth rates (CAGRs) through 2015. A breakdown of the fetal monitoring segment, including electronic monitors, handheld Doppler devices, telemetry monitoring, amnioscopy, and infant heart rate and apnea monitoring; and the diagnostics segment, including ultrasound, X-rays, chorionic villus sampling, alpha-fetoprotein testing, and pregnancy confirmation testing. Discussions of regulatory issues and new developments. Comprehensive company profiles and patent analyses.
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for fetal monitoring and diagnosis, including neonatal monitoring. The key objective is to present a comprehensive analysis of the current market and its future direction in the fetal and neonatal monitoring market with the utilization of the techniques and devices available for preventing fetal diseases.
This report explores present and future strategies within the fetal monitoring and diagnosis market, including prenatal and neonatal monitoring and diagnosis. The market's current state, its setbacks, its innovations, and its future needs are discussed in this report. A general overview of fetus testing techniques and devices, as well as related technologies used currently and in the past, are discussed in this report.
A detailed analysis of the fetal and neonatal monitoring and diagnosis industry structure has been conducted. This includes all the categories of monitoring and diagnosis broken down by market share that belong to leading manufacturers and/or suppliers. Revenues for each of the categories are broken down by region. Sales figures are estimated for the 5-year period from 2011 through 2016.
Applications for fetal monitoring and diagnosis, (including neonatal monitoring) for usage in antepartum and intrapartum are also discussed separately in the report by region. The markets in diagnosing cardiopulmonary diseases in neonates are also studied. The report includes significant patents and their allotments in each category of fetal monitoring and diagnosis.
REASONS FOR DOING THIS STUDY
This study was conducted to provide vital and detailed information regarding fetal and neonatal monitoring and diagnosing. This industry is experiencing growth, as the concept of fetus as a patient has changed the entire industry. Technological advancements have made it possible to access and monitor the fetus. This study was conducted to provide detailed analysis of the market along with the different factors that affect it. The rising number of high-risk pregnancies is placing greater demands of advanced fetal-maternal monitoring during both the antepartum and intrapartum delivery of care during pregnancy.
Acquisitions, mergers, and alliances by companies and global organizations are covered in this report. The study also discusses the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the arena of devices and predictive tests used during various stages of pregnancy that may help prevent some diseases through early detection. It will be of interest to clinicians, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutions.
SCOPE OF THE STUDY
The scope of this study encompasses the fetal monitoring and diagnostics markets. BCC analyzes each market and its applications by its need for usage in different stages of pregnancy, along with the regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search that included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with various pharmaceutical and biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
CHAPTER ONE: INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: EXECUTIVE SUMMARY
EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, THROUGH 2016 ($ BILLIONS)
SUMMARY FIGURE GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, 2009-2016 ($ BILLIONS)
CHAPTER THREE: OVERVIEW
DEFINITIONS
TYPES OF FETAL MONITORING
EXTERNAL FETAL MONITORING
Need of External Fetal Monitoring
Advantages and Disadvantages of External Fetal Monitoring
TABLE 1 ADVANTAGES AND DISADVANTAGES OF EXTERNAL FETAL MONITORING
INTERNAL FETAL MONITORING
Advantages and Disadvantages of Internal Fetal Monitoring
TABLE 2 ADVANTAGES AND DISADVANTAGES OF INTERNAL FETAL MONITORING
TABLE 3 EXTERNAL FETAL MONITORING VERSUS INTERNAL FETAL MONITORING
TYPES OF FETAL MONITORS
FETOSCOPE
DOPPLER
ELECTRONIC FETAL MONITOR
Denigration of the Routine Use of Electronic Fetal Monitoring
TELEMETRY
INTERNAL FETAL MONITOR
PRENATAL DIAGNOSIS
NEED OF PRENATAL DIAGNOSIS
PREREQUISITES OF PRENATAL DIAGNOSIS
ADVANTAGES OF PRENATAL DIAGNOSIS
TECHNIQUES FOR PRENATAL DIAGNOSIS
Noninvasive Prenatal Diagnosis Techniques
Fetal Cells in Maternal Blood
Preimplantation Genetic Diagnosis
Ultrasonography
Magnetic Resonance Imaging Test
Ultrasound Versus MRI in Fetal Diagnosis
TABLE 4 ULTRASOUND VERSUS MRI
Non-Stress Test
Florescence In Situ Hybridization
New Noninvasive Nucleic Acid Technologies
Cell-Free DNA Technologies
Transrenal DNA Technology
Less-Invasive Prenatal Diagnosis Techniques
Maternal Serum Screening
Transcervical Retrieval of Trophoblast Cells
Detection of Fetal Blood Cells in Maternal Blood
More-Invasive Prenatal Diagnosis Techniques
Amniocentesis
Chorionic Villus Sampling
Percutaneous Umbilical Blood Sampling
Skin and Organ Biopsy
CHAPTER FOUR: REGULATORY ASPECTS
REGULATORY ASPECTS
PREMARKET CLEARANCE AND 510(K) CLEARANCES
TABLE 5 PRE-MARKET APPROVALS, 2006 TO DECEMBER 2010
CHAPTER FIVE: CLASSIFICATION
FETAL MONITORING
FETAL DOPPLERS
ELECTRONIC FETAL MONITORS
OTHER FETAL EQUIPMENT AND INSTRUMENTS
PRENATAL DIAGNOSIS
ULTRASOUND AND ULTRASONOGRAPHY
FETAL MAGNETIC RESONANCE IMAGING
AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING
OTHER TESTS
NEONATAL MONITORING
CHAPTER SIX: TESTS FOR GENETIC DISORDERS
DOMINANT GENE DISORDERS
HUNTINGTON'S DISEASE
ACHONDROPLASIA
RECESSIVE GENE DISORDERS
CYSTIC FIBROSIS
SICKLE CELL DISEASE
TAY-SACHS DISEASE
BETA THALASSEMIA
X-LINKED DISORDERS
HEMOPHILIA
CHROMOSOMAL DISORDERS
DOWN SYNDROME
TURNER'S SYNDROME
CHAPTER SEVEN: INDUSTRY STRUCTURE
MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS AND DIAGNOSTIC INSTRUMENTS
FETAL DOPPLER
TABLE 6 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS
FETAL MONITORS
TABLE 7 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS
FETAL SCALP ELECTRODES, FETOSCOPES, AND CATHETERS
TABLE 8 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL SCALP ELECTRODES, FETOSCOPES, AND CATHETERS
ULTRASOUND SYSTEMS
TABLE 9 LEADING MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS
MRI SYSTEMS
TABLE 10 LEADING MANUFACTURERS AND SUPPLIERS OF MRI SYSTEMS
NEONATAL SYSTEMS
TABLE 11 LEADING MANUFACTURERS AND SUPPLIERS OF NEONATAL SYSTEMS
MARKET SHARES OF INDUSTRY LEADERS OF FETAL MONITORING SYSTEMS AND DIAGNOSTICS
FETAL DOPPLERS
TABLE 12 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS, 2010 (%)
FIGURE 1 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS, 2010 (%)
FETAL MONITORS
TABLE 13 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS, 2010 (%)
FIGURE 2 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS, 2010 (%)
OTHER FETAL MONITORING DEVICES
TABLE 14 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER FETAL MONITORING DEVICES, 2010 (%)
FIGURE 3 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER FETAL MONITORING DEVICES, 2010 (%)
TABLE 15 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS IN FETAL
MONITORING AND DIAGNOSIS, 2010 (%)
FIGURE 4 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
MAGNETIC RESONANCE IMAGING IN FETAL MONITORING AND DIAGNOSIS
TABLE 16 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC RESONANCE IMAGING SYSTEMS USED IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
FIGURE 5 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC RESONANCE IMAGING IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
NEONATAL MONITORING SYSTEMS
TABLE 17 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL MONITORING SYSTEMS, 2010 (%)
FIGURE 6 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL MONITORING SYSTEMS, 2010 (%)
CHAPTER EIGHT: NEW DEVELOPMENTS
NEW DEVELOPMENTS
TABLE 18 NEW DEVELOPMENTS, 2008-FEBRUARY 2011
OTHERS
CHAPTER NINE: MARKET ANALYSIS
MARKET ANALYSIS
MARKET REVENUE
TABLE 19 GLOBAL MARKET FOR FETAL MONITORING AND DIAGNOSTICS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FOR FETAL MONITORING AND DIAGNOSTICS BY REGION, 2009-2016 ($ MILLIONS)
FETAL MONITORING
FETAL DOPPLER
Market Overview
Market Revenue
TABLE 20 GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 8 GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, 2009-2016 ($ MILLIONS)
FETAL MONITORS
Market Overview
Market Revenue
TABLE 21 GLOBAL MARKET FOR FETAL MONITORS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 9 GLOBAL MARKET FOR FETAL MONITORS BY REGION, 2009-2016 ($ MILLIONS)
OTHERS
Market Overview
Market Revenue
TABLE 22 GLOBAL MARKET FOR OTHERS CATEGORY OF FETAL MONITORING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 10 GLOBAL MARKET FOR OTHERS CATEGORY FOR FETAL MONITORING BY REGION, 2009-2016 ($ MILLIONS)
PRENATAL DIAGNOSTICS
ULTRASONOGRAPHY
Market Overview
Market Revenue
TABLE 23 GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND ULTRASONOGRAPHY BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND ULTRASONOGRAPHY BY REGION, 2009-2016 ($ MILLIONS)
MAGNETIC RESONANCE IMAGING
Market Overview
Market Revenue
TABLE 24 GLOBAL MARKET FOR PRENATAL MONITORING BY MAGNETIC RESONANCE IMAGING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 12 GLOBAL MARKET FOR PRENATAL MONITORING BY MAGNETIC RESONANCE IMAGING BY REGION, 2009-2016 ($ MILLIONS)
AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING
Market Overview
Market Revenue
TABLE 25 GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 13 GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND CHRIONIC VILLUS SAMPLING BY REGION, 2009-2016 ($ MILLIONS)
SCREENING TESTS AND OTHER TESTS
Market Overview
Market Revenue
TABLE 26 GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER TESTS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER TESTS BY REGION, 2009-2016 ($ MILLIONS)
NEONATAL MONITORING
Market Overview
Market Revenue
TABLE 27 GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, 2009-2016 ($ MILLIONS)
MARKET SHARES OF FETAL MONITORING AND DIAGNOSIS BY REGION
TABLE 28 GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY REGION, 2010 (%)
FIGURE 16 GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY REGION, 2010 (%)
CHAPTER TEN: MARKET BY APPLICATIONS
ANTEPARTUM FETAL MONITORING
MARKET REVENUE
TABLE 29 GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS, THROUGH 2016 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS, 2009-2016 ($ MILLIONS)
INTRAPARTUM FETAL MONITORING
MARKET REVENUE
TABLE 30 GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS, THROUGH 2016 ($ MILLIONS)
FIGURE 18 GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS, 2009-2016 ($ MILLIONS)
NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES
MARKET REVENUE
TABLE 31 GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES, 2009-2016 ($ MILLIONS)
Neonatal Monitoring for Congenital Heart Diseases
TABLE 32 GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENITAL HEART DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 20 GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENITAL HEART DISEASE, 2009-2016 ($ MILLIONS)
Neonatal Monitoring for Pulmonary Diseases
TABLE 33 GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 21 GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES, 2009-2016 ($ MILLIONS)
MARKET SHARE OF APPLICATIONS
TABLE 34 SHARES OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS BY APPLICATION, 2010 (%)
FIGURE 22 SHARE OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS BY APPLICATION, 2010 (%)
CHAPTER ELEVEN: PATENT ANALYSIS
PATENTS BY YEAR
TABLE 35 SIGNIFICANT PATENTS BY YEAR, 2007-2011
FIGURE 23 PATENTS BY YEAR, 2007-2011
FIGURE 24 PATENTS BY YEAR, 2007-2011 (%)
PATENTS BY TYPE
TABLE 36 PATENTS BY TYPE, 2007-2011
FIGURE 25 TOTAL PATENTS BY TYPE, 2007-2011 (%)
PATENTS BY COMPANY
FETAL MONITORING
TABLE 37 U.S. PATENTS BY COMPANY FOR FETAL MONITORING, 2007-2011
PRENATAL DIAGNOSIS
TABLE 38 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COMPANY, 2007-2011
NEONATAL MONITORING
TABLE 39 U.S. PATENTS FOR NEONATAL MONITORING BY COMPANY, 2007-2011
PATENTS BY COUNTRY
FETAL MONITORING
TABLE 40 U.S. PATENTS FOR FETAL MONITORING BY COUNTRY, 2007-2011
PRENATAL DIAGNOSIS
TABLE 41 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007-2011
FIGURE 26 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007-2011
NEONATAL MONITORING
TABLE 42 U.S. PATENTS FOR NEONATAL MONITORING BY COUNTRY, 2007-2011
TABLE 43 U.S. PATENTS FOR ALL FETAL AND NEONATAL MONITORING AND DIAGNOSIS BY COUNTRY, 2007-2011 (%)
FIGURE 27 PATENT SHARES FOR ALL FETAL AND NEONATAL MONITORING AND DIAGNOSIS BY COUNTRY, 2007-2011 (%)
PATENTS BY ASSIGNEE
FETAL MONITORING
TABLE 44 PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007-2011
FIGURE 28 PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007-2011
PRENATAL DIAGNOSIS
TABLE 45 PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007-2011
FIGURE 29 PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007-2011
NEONATAL MONITORING
TABLE 46 PATENTS FOR NEONATAL MONITORING BY ASSIGNEE TYPE, 2007-2011
CHAPTER TWELVE: FETAL MONITORING AND PRENATAL DIAGNOSTICS TO HELP REDUCE STILLBIRTHS
FETAL MONITORING AND PRENATAL …
CHAPTER THIRTEEN: CURRENT SITUATION AND MARKET PROSPECTS
FACTORS AFFECTING THE MARKET
INCREASING AWARENESS
ADVANCED MATERNAL AGE
AVAILABILITY OF MONITORING AND DIAGNOSTIC
DEVICES
MEDICAL REIMBURSEMENTS
MERGERS AND ACQUISITIONS
COLLABORATIONS AND AGREEMENTS
FUTURE PROSPECTS OF THE MARKETS
CHAPTER FOURTEEN: COMPANY PROFILES
ALIMED INC.
ALLEN MEDICAL INSTRUMENTS CORPORATION
ANALOGIC CORPORATION
ATOM MEDICAL CORPORATION
BIONET AMERICA INC.
CARDINAL HEALTH
CAREFUSION CORPORATION
CAS MEDICAL SYSTEMS, INC.
CLINICAL INNOVATIONS, INC.
COOPER SURGICAL, INC.
COVIDIEN
DRE MEDICAL EQUIPMENTS
ESAOTE SA
FONAR CORPORATION
GE HEALTHCARE
GIMA PROFESSIONAL MEDICAL PRODUCTS
HITACHI MEDICAL SYSTEMS, INC.
ARJOHUNTLEIGH
MASIMO CORPORATION
MED-ELECTRONICS, INC.
MEDISON AMERICA, INC.
MEDLINE INDUSTRIES
NEOVENTA MEDICAL, INC.
NIHON KOHDEN CORPORATION
NONIN MEDICAL, INC.
PARAMED MEDICAL SYSTEMS
PHILIPS HEALTHCARE
ROCKET MEDICAL, PLC
SHENZHEN OSEN TECHNOLOGY CO., LTD.
SHIMADZU EUROPE, GMBH
SIEMENS HEALTHCARE
SONOSITE, INC.
SUMMIT DOPPLER
SUNRAY MEDICAL APPARATUS COMPANY, LTD.
SUPERIOR MEDICAL, LTD.
TERASON ULTRASOUND
THAMES MEDICAL, LTD.
TOSHIBA AMERICA MEDICAL SYSTEMS, INC.
UTAH MEDICAL PRODUCTS, INC.
WALLACH SURGICAL DEVICES, INC.
APPENDIX I: ABBREVIATIONS AND DEFINITIONS
ABBREVIATIONS AND DEFINITIONS
ABBREVIATIONS AND DEFINITIONS (CONTINUED)
More Details
To order this report:
Diagnostics Industry: Fetal Monitoring, Diagnostics and Predictive Tests
Diagnostics Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Fetal Monitoring, Diagnostics and Predictive Tests
http://www.reportlinker.com/p0490902/Fetal-Monitoring-Diagnostics-and-Predictive-Tests.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics
Advertisement
An overview of the market for fetal monitoring, diagnostics, and predictive tests. Analysis of market trends, with data from 2009, estimates for 2010, and projections of compound annual growth rates (CAGRs) through 2015. A breakdown of the fetal monitoring segment, including electronic monitors, handheld Doppler devices, telemetry monitoring, amnioscopy, and infant heart rate and apnea monitoring; and the diagnostics segment, including ultrasound, X-rays, chorionic villus sampling, alpha-fetoprotein testing, and pregnancy confirmation testing. Discussions of regulatory issues and new developments. Comprehensive company profiles and patent analyses.
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for fetal monitoring and diagnosis, including neonatal monitoring. The key objective is to present a comprehensive analysis of the current market and its future direction in the fetal and neonatal monitoring market with the utilization of the techniques and devices available for preventing fetal diseases.
This report explores present and future strategies within the fetal monitoring and diagnosis market, including prenatal and neonatal monitoring and diagnosis. The market's current state, its setbacks, its innovations, and its future needs are discussed in this report. A general overview of fetus testing techniques and devices, as well as related technologies used currently and in the past, are discussed in this report.
A detailed analysis of the fetal and neonatal monitoring and diagnosis industry structure has been conducted. This includes all the categories of monitoring and diagnosis broken down by market share that belong to leading manufacturers and/or suppliers. Revenues for each of the categories are broken down by region. Sales figures are estimated for the 5-year period from 2011 through 2016.
Applications for fetal monitoring and diagnosis, (including neonatal monitoring) for usage in antepartum and intrapartum are also discussed separately in the report by region. The markets in diagnosing cardiopulmonary diseases in neonates are also studied. The report includes significant patents and their allotments in each category of fetal monitoring and diagnosis.
REASONS FOR DOING THIS STUDY
This study was conducted to provide vital and detailed information regarding fetal and neonatal monitoring and diagnosing. This industry is experiencing growth, as the concept of fetus as a patient has changed the entire industry. Technological advancements have made it possible to access and monitor the fetus. This study was conducted to provide detailed analysis of the market along with the different factors that affect it. The rising number of high-risk pregnancies is placing greater demands of advanced fetal-maternal monitoring during both the antepartum and intrapartum delivery of care during pregnancy.
Acquisitions, mergers, and alliances by companies and global organizations are covered in this report. The study also discusses the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the arena of devices and predictive tests used during various stages of pregnancy that may help prevent some diseases through early detection. It will be of interest to clinicians, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutions.
SCOPE OF THE STUDY
The scope of this study encompasses the fetal monitoring and diagnostics markets. BCC analyzes each market and its applications by its need for usage in different stages of pregnancy, along with the regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search that included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with various pharmaceutical and biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
CHAPTER ONE: INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: EXECUTIVE SUMMARY
EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, THROUGH 2016 ($ BILLIONS)
SUMMARY FIGURE GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, 2009-2016 ($ BILLIONS)
CHAPTER THREE: OVERVIEW
DEFINITIONS
TYPES OF FETAL MONITORING
EXTERNAL FETAL MONITORING
Need of External Fetal Monitoring
Advantages and Disadvantages of External Fetal Monitoring
TABLE 1 ADVANTAGES AND DISADVANTAGES OF EXTERNAL FETAL MONITORING
INTERNAL FETAL MONITORING
Advantages and Disadvantages of Internal Fetal Monitoring
TABLE 2 ADVANTAGES AND DISADVANTAGES OF INTERNAL FETAL MONITORING
TABLE 3 EXTERNAL FETAL MONITORING VERSUS INTERNAL FETAL MONITORING
TYPES OF FETAL MONITORS
FETOSCOPE
DOPPLER
ELECTRONIC FETAL MONITOR
Denigration of the Routine Use of Electronic Fetal Monitoring
TELEMETRY
INTERNAL FETAL MONITOR
PRENATAL DIAGNOSIS
NEED OF PRENATAL DIAGNOSIS
PREREQUISITES OF PRENATAL DIAGNOSIS
ADVANTAGES OF PRENATAL DIAGNOSIS
TECHNIQUES FOR PRENATAL DIAGNOSIS
Noninvasive Prenatal Diagnosis Techniques
Fetal Cells in Maternal Blood
Preimplantation Genetic Diagnosis
Ultrasonography
Magnetic Resonance Imaging Test
Ultrasound Versus MRI in Fetal Diagnosis
TABLE 4 ULTRASOUND VERSUS MRI
Non-Stress Test
Florescence In Situ Hybridization
New Noninvasive Nucleic Acid Technologies
Cell-Free DNA Technologies
Transrenal DNA Technology
Less-Invasive Prenatal Diagnosis Techniques
Maternal Serum Screening
Transcervical Retrieval of Trophoblast Cells
Detection of Fetal Blood Cells in Maternal Blood
More-Invasive Prenatal Diagnosis Techniques
Amniocentesis
Chorionic Villus Sampling
Percutaneous Umbilical Blood Sampling
Skin and Organ Biopsy
CHAPTER FOUR: REGULATORY ASPECTS
REGULATORY ASPECTS
PREMARKET CLEARANCE AND 510(K) CLEARANCES
TABLE 5 PRE-MARKET APPROVALS, 2006 TO DECEMBER 2010
CHAPTER FIVE: CLASSIFICATION
FETAL MONITORING
FETAL DOPPLERS
ELECTRONIC FETAL MONITORS
OTHER FETAL EQUIPMENT AND INSTRUMENTS
PRENATAL DIAGNOSIS
ULTRASOUND AND ULTRASONOGRAPHY
FETAL MAGNETIC RESONANCE IMAGING
AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING
OTHER TESTS
NEONATAL MONITORING
CHAPTER SIX: TESTS FOR GENETIC DISORDERS
DOMINANT GENE DISORDERS
HUNTINGTON'S DISEASE
ACHONDROPLASIA
RECESSIVE GENE DISORDERS
CYSTIC FIBROSIS
SICKLE CELL DISEASE
TAY-SACHS DISEASE
BETA THALASSEMIA
X-LINKED DISORDERS
HEMOPHILIA
CHROMOSOMAL DISORDERS
DOWN SYNDROME
TURNER'S SYNDROME
CHAPTER SEVEN: INDUSTRY STRUCTURE
MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS AND DIAGNOSTIC INSTRUMENTS
FETAL DOPPLER
TABLE 6 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS
FETAL MONITORS
TABLE 7 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS
FETAL SCALP ELECTRODES, FETOSCOPES, AND CATHETERS
TABLE 8 LEADING MANUFACTURERS AND SUPPLIERS OF FETAL SCALP ELECTRODES, FETOSCOPES, AND CATHETERS
ULTRASOUND SYSTEMS
TABLE 9 LEADING MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS
MRI SYSTEMS
TABLE 10 LEADING MANUFACTURERS AND SUPPLIERS OF MRI SYSTEMS
NEONATAL SYSTEMS
TABLE 11 LEADING MANUFACTURERS AND SUPPLIERS OF NEONATAL SYSTEMS
MARKET SHARES OF INDUSTRY LEADERS OF FETAL MONITORING SYSTEMS AND DIAGNOSTICS
FETAL DOPPLERS
TABLE 12 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS, 2010 (%)
FIGURE 1 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS, 2010 (%)
FETAL MONITORS
TABLE 13 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS, 2010 (%)
FIGURE 2 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS, 2010 (%)
OTHER FETAL MONITORING DEVICES
TABLE 14 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER FETAL MONITORING DEVICES, 2010 (%)
FIGURE 3 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER FETAL MONITORING DEVICES, 2010 (%)
TABLE 15 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS IN FETAL
MONITORING AND DIAGNOSIS, 2010 (%)
FIGURE 4 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
MAGNETIC RESONANCE IMAGING IN FETAL MONITORING AND DIAGNOSIS
TABLE 16 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC RESONANCE IMAGING SYSTEMS USED IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
FIGURE 5 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC RESONANCE IMAGING IN FETAL MONITORING AND DIAGNOSIS, 2010 (%)
NEONATAL MONITORING SYSTEMS
TABLE 17 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL MONITORING SYSTEMS, 2010 (%)
FIGURE 6 GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL MONITORING SYSTEMS, 2010 (%)
CHAPTER EIGHT: NEW DEVELOPMENTS
NEW DEVELOPMENTS
TABLE 18 NEW DEVELOPMENTS, 2008-FEBRUARY 2011
OTHERS
CHAPTER NINE: MARKET ANALYSIS
MARKET ANALYSIS
MARKET REVENUE
TABLE 19 GLOBAL MARKET FOR FETAL MONITORING AND DIAGNOSTICS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FOR FETAL MONITORING AND DIAGNOSTICS BY REGION, 2009-2016 ($ MILLIONS)
FETAL MONITORING
FETAL DOPPLER
Market Overview
Market Revenue
TABLE 20 GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 8 GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, 2009-2016 ($ MILLIONS)
FETAL MONITORS
Market Overview
Market Revenue
TABLE 21 GLOBAL MARKET FOR FETAL MONITORS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 9 GLOBAL MARKET FOR FETAL MONITORS BY REGION, 2009-2016 ($ MILLIONS)
OTHERS
Market Overview
Market Revenue
TABLE 22 GLOBAL MARKET FOR OTHERS CATEGORY OF FETAL MONITORING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 10 GLOBAL MARKET FOR OTHERS CATEGORY FOR FETAL MONITORING BY REGION, 2009-2016 ($ MILLIONS)
PRENATAL DIAGNOSTICS
ULTRASONOGRAPHY
Market Overview
Market Revenue
TABLE 23 GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND ULTRASONOGRAPHY BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND ULTRASONOGRAPHY BY REGION, 2009-2016 ($ MILLIONS)
MAGNETIC RESONANCE IMAGING
Market Overview
Market Revenue
TABLE 24 GLOBAL MARKET FOR PRENATAL MONITORING BY MAGNETIC RESONANCE IMAGING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 12 GLOBAL MARKET FOR PRENATAL MONITORING BY MAGNETIC RESONANCE IMAGING BY REGION, 2009-2016 ($ MILLIONS)
AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING
Market Overview
Market Revenue
TABLE 25 GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND CHORIONIC VILLUS SAMPLING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 13 GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND CHRIONIC VILLUS SAMPLING BY REGION, 2009-2016 ($ MILLIONS)
SCREENING TESTS AND OTHER TESTS
Market Overview
Market Revenue
TABLE 26 GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER TESTS BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER TESTS BY REGION, 2009-2016 ($ MILLIONS)
NEONATAL MONITORING
Market Overview
Market Revenue
TABLE 27 GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, THROUGH 2016 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, 2009-2016 ($ MILLIONS)
MARKET SHARES OF FETAL MONITORING AND DIAGNOSIS BY REGION
TABLE 28 GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY REGION, 2010 (%)
FIGURE 16 GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY REGION, 2010 (%)
CHAPTER TEN: MARKET BY APPLICATIONS
ANTEPARTUM FETAL MONITORING
MARKET REVENUE
TABLE 29 GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS, THROUGH 2016 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS, 2009-2016 ($ MILLIONS)
INTRAPARTUM FETAL MONITORING
MARKET REVENUE
TABLE 30 GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS, THROUGH 2016 ($ MILLIONS)
FIGURE 18 GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS, 2009-2016 ($ MILLIONS)
NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES
MARKET REVENUE
TABLE 31 GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES, 2009-2016 ($ MILLIONS)
Neonatal Monitoring for Congenital Heart Diseases
TABLE 32 GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENITAL HEART DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 20 GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENITAL HEART DISEASE, 2009-2016 ($ MILLIONS)
Neonatal Monitoring for Pulmonary Diseases
TABLE 33 GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES, THROUGH 2016 ($ MILLIONS)
FIGURE 21 GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES, 2009-2016 ($ MILLIONS)
MARKET SHARE OF APPLICATIONS
TABLE 34 SHARES OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS BY APPLICATION, 2010 (%)
FIGURE 22 SHARE OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS BY APPLICATION, 2010 (%)
CHAPTER ELEVEN: PATENT ANALYSIS
PATENTS BY YEAR
TABLE 35 SIGNIFICANT PATENTS BY YEAR, 2007-2011
FIGURE 23 PATENTS BY YEAR, 2007-2011
FIGURE 24 PATENTS BY YEAR, 2007-2011 (%)
PATENTS BY TYPE
TABLE 36 PATENTS BY TYPE, 2007-2011
FIGURE 25 TOTAL PATENTS BY TYPE, 2007-2011 (%)
PATENTS BY COMPANY
FETAL MONITORING
TABLE 37 U.S. PATENTS BY COMPANY FOR FETAL MONITORING, 2007-2011
PRENATAL DIAGNOSIS
TABLE 38 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COMPANY, 2007-2011
NEONATAL MONITORING
TABLE 39 U.S. PATENTS FOR NEONATAL MONITORING BY COMPANY, 2007-2011
PATENTS BY COUNTRY
FETAL MONITORING
TABLE 40 U.S. PATENTS FOR FETAL MONITORING BY COUNTRY, 2007-2011
PRENATAL DIAGNOSIS
TABLE 41 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007-2011
FIGURE 26 U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007-2011
NEONATAL MONITORING
TABLE 42 U.S. PATENTS FOR NEONATAL MONITORING BY COUNTRY, 2007-2011
TABLE 43 U.S. PATENTS FOR ALL FETAL AND NEONATAL MONITORING AND DIAGNOSIS BY COUNTRY, 2007-2011 (%)
FIGURE 27 PATENT SHARES FOR ALL FETAL AND NEONATAL MONITORING AND DIAGNOSIS BY COUNTRY, 2007-2011 (%)
PATENTS BY ASSIGNEE
FETAL MONITORING
TABLE 44 PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007-2011
FIGURE 28 PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007-2011
PRENATAL DIAGNOSIS
TABLE 45 PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007-2011
FIGURE 29 PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007-2011
NEONATAL MONITORING
TABLE 46 PATENTS FOR NEONATAL MONITORING BY ASSIGNEE TYPE, 2007-2011
CHAPTER TWELVE: FETAL MONITORING AND PRENATAL DIAGNOSTICS TO HELP REDUCE STILLBIRTHS
FETAL MONITORING AND PRENATAL …
CHAPTER THIRTEEN: CURRENT SITUATION AND MARKET PROSPECTS
FACTORS AFFECTING THE MARKET
INCREASING AWARENESS
ADVANCED MATERNAL AGE
AVAILABILITY OF MONITORING AND DIAGNOSTIC
DEVICES
MEDICAL REIMBURSEMENTS
MERGERS AND ACQUISITIONS
COLLABORATIONS AND AGREEMENTS
FUTURE PROSPECTS OF THE MARKETS
CHAPTER FOURTEEN: COMPANY PROFILES
ALIMED INC.
ALLEN MEDICAL INSTRUMENTS CORPORATION
ANALOGIC CORPORATION
ATOM MEDICAL CORPORATION
BIONET AMERICA INC.
CARDINAL HEALTH
CAREFUSION CORPORATION
CAS MEDICAL SYSTEMS, INC.
CLINICAL INNOVATIONS, INC.
COOPER SURGICAL, INC.
COVIDIEN
DRE MEDICAL EQUIPMENTS
ESAOTE SA
FONAR CORPORATION
GE HEALTHCARE
GIMA PROFESSIONAL MEDICAL PRODUCTS
HITACHI MEDICAL SYSTEMS, INC.
ARJOHUNTLEIGH
MASIMO CORPORATION
MED-ELECTRONICS, INC.
MEDISON AMERICA, INC.
MEDLINE INDUSTRIES
NEOVENTA MEDICAL, INC.
NIHON KOHDEN CORPORATION
NONIN MEDICAL, INC.
PARAMED MEDICAL SYSTEMS
PHILIPS HEALTHCARE
ROCKET MEDICAL, PLC
SHENZHEN OSEN TECHNOLOGY CO., LTD.
SHIMADZU EUROPE, GMBH
SIEMENS HEALTHCARE
SONOSITE, INC.
SUMMIT DOPPLER
SUNRAY MEDICAL APPARATUS COMPANY, LTD.
SUPERIOR MEDICAL, LTD.
TERASON ULTRASOUND
THAMES MEDICAL, LTD.
TOSHIBA AMERICA MEDICAL SYSTEMS, INC.
UTAH MEDICAL PRODUCTS, INC.
WALLACH SURGICAL DEVICES, INC.
APPENDIX I: ABBREVIATIONS AND DEFINITIONS
ABBREVIATIONS AND DEFINITIONS
ABBREVIATIONS AND DEFINITIONS (CONTINUED)
More Details
To order this report:
Diagnostics Industry: Fetal Monitoring, Diagnostics and Predictive Tests
Diagnostics Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
